Active continuous sequential compression treatment
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,033
NCT04659564
Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study
Phase: N/A
Role: Lead Sponsor
Start: Aug 5, 2020
Completion: May 28, 2021
NCT04828590
The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease
Start: Aug 10, 2020
Completion: Dec 31, 2021
NCT04888975
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
Start: Jun 1, 2021
NCT04897035
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema
Completion: Jul 1, 2022
NCT04908254
A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema
NCT05507346
A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema
Start: Sep 6, 2022
Completion: Jan 9, 2024
NCT06172985
A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease
Start: May 9, 2023
Completion: Feb 29, 2024
NCT05628688
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA)
Start: Aug 8, 2023
Completion: Aug 28, 2024
NCT06418282
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
Start: May 13, 2024
Completion: Jan 31, 2025
NCT06711822
The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification
Start: Jul 1, 2024
Completion: Dec 30, 2025
Loading map...